HIGHLIGHTS
- who: Shonagh Russell and colleagues from the Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA have published the paper: Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer, in the Journal: Cancers 2022, 14, 4219. of /2022/
- what: The development of the STOSE.M1 luc model offers another pre-clinical model for conducting translational ovarian cancer research.
- how: To address this problem the authors developed a luciferase labeled murine model of high-grade serous cancer STOSE.M1 luc. The flow cytometry data were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.